National antiviral treatment program and the incidence of hepatocellular carcinoma and associated mortality in taiwan: A preliminary report
Journal
Medical Care
Journal Volume
51
Journal Issue
10
Pages
908-913
Date Issued
2013
Author(s)
Abstract
BACKGROUND
SDGs
Other Subjects
adefovir; alpha2a interferon; alpha2b interferon; antivirus agent; entecavir; lamivudine; peginterferon alpha2a; peginterferon alpha2b; ribavirin; telbivudine; tenofovir; adult; aged; antiviral therapy; article; cancer incidence; cancer mortality; cancer registry; data base; female; hepatitis B; hepatitis C; human; liver cell carcinoma; major clinical study; male; national health insurance; priority journal; Taiwan; time series analysis; Adult; Age Distribution; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Comorbidity; Female; Hepatitis B; Hepatitis C; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Sex Distribution; State Medicine; Survival Rate; Taiwan
Type
journal article